The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tinengotinib (TT-00420) in combination with atezolizumab in Chinese patients (pts) with biliary tract carcinoma (BTC): Preliminary efficacy and safety results from a phase Ib/II study.
 
Panpan Zhang
No Relationships to Disclose
 
Jifang Gong
No Relationships to Disclose
 
Zuoxing Niu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Jean Fan
Employment - TransThera Biosciences
Leadership - TransThera Biosciences
Stock and Other Ownership Interests - AstraZeneca
 
Peng Peng
Employment - TransThera Sciences (Nanjing), Inc.
Stock and Other Ownership Interests - TransThera Sciences (Nanjing), Inc.
Patents, Royalties, Other Intellectual Property - PCT/CN2022/091924 (Inst)
 
Caixia Sun
Employment - TransThera Sciences (Nanjing), Inc.
 
Hui Wang
No Relationships to Disclose
 
Yingying Yu
No Relationships to Disclose
 
Yujia Zhu
Employment - TransThera Sciences (Nanjing), Inc.
 
Yingtong Wu
No Relationships to Disclose
 
Qing Li
Employment - TransThera Sciences (Nanjing), Inc.
 
Peng Huang
Employment - TransThera Sciences (Nanjing), Inc.
 
Frank Wu
Leadership - TransThera Sciences (Nanjing), Inc.
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)